Brief: Cullinan Therapeutics Q2 Operating Income USD -57.254 Million Vs. IBES Estimate USD -57.1 Million
BRIEF-Cullinan Therapeutics Q2 Operating Income USD -57.254 Million Vs. IBES Estimate USD -57.1 Million Aug 06 (Reuters) - Cullinan Therapeutics Q2 net income USD -53.704 million.
- Q2 operating expenses USD 57.254 million
- Q2 cash & investments USD 356 million